Ram Sarfaty

Ivory Graft Ltd. has developed a naturally sourced, bioresorbable dentin graft material for the repair and augmentation of bone defects. Privately held, the company was founded and is funded by leading clinicians and industry leaders. Located in central Israel, Ivory Graft benefits from the country’s innovative medical startup ecosystem. Ivory Dentin Graft™ - The First and Only Dentin Graft The Ivory Dentin Graft™ was developed based upon years of scientific research and peer-reviewed publications on the advantages of autologous dentin grafts. Dentin’s composition is very similar to bone, due to its high mineral phase and its tubular architecture. Dentin is considered an excellent bone graft substitute grafting material. Ivory Dentin Graft is an active organic matrix. It retains the natural form of the sourced porcine dentin as well as the protein matrix consisting largely of collagen, and has been adapted for use in dental procedures. For the best results and ideal hard tissue generation, physicomechanical properties of the graft should match that of the host bone, in addition to biological connectivity and bio-active organic matrix. Ivory Dentin Graft promotes new bone formation as well as promoting good integration between the host-bone and graft material. These two features are important for tissue regeneration and integration during early bone remodeling processes that follow tooth extraction and grafting, and facilitate osteogenic activity to promote successful subsequent implant placement. CE Marked (MDR 2017/745), Ivory Dentin Graft™ is a graft substitute, naturally sourced from porcine dentin, obtained by standardized and controlled manufacturing procedures. This unique dentin graft is safe and effective, has no additives, and carries no BSE risk. In the USA, Ivory Dentin Graft™ is not yet available for commercial use .

Using Advanced AI and Protein intelligence to introduce indication-specific functional proteins with a perfect fit for humans.

DentQ International is the world’s biggest network of Dental Imaging Centers. Join us and enjoy the most advanced dental imaging solutions at dozens of branches around the world. The global DentQ group provides Dental Imaging services under the newer brand DentQ – launched in 2021 in 4 branches in Italy, and the older brand CTdent, that represents dozens of branches in England, Hong-Kong, Lithuania, Georgia and Israel since 1996. Our services include CT, OPG and CEPH scans, detailed radiological reports, intra-oral scans, and much more. The specialized Dental CBCT scanners (Cone Bean CT) that we use bring highly accurate, in-depth and vital 3D information to the dentist, while using 80% less radiation to keep the patient safe. At DentQ, we offer the most advanced technologies, to enable the best dental care and the utmost convenience for patients and for their dentists. We use innovative AI solutions for precise root canal marking, detection of damages and classification of each tooth, as well as implant study and Endo study. DentQ also provides the first ever Dental PACS solution – a medical imaging technology for securely storing and digitally transmitting electronic images and clinically-relevant reports, with outstanding convenience and usability. We integrated dental PACS to the benefit of more than 18,000 dentists that work with us and enjoy results on the spot. We also provide dedicated 3D viewers, intuitive surgery planning tools, online reference and booking platform, and training to dentists and Implantologists. With DentQ on their side, dentists save time and know that everything is under control. 98% of our patients are highly satisfied when they visit us at DentQ according to an on-going survey. This all makes sense, since, after all, we are the biggest network of Dental Imaging Centers in the world, and we truly understand that it all starts with happy clients. Come visit our website to learn more about DentQ.

Ivory Graft Ltd. has developed a naturally sourced, bioresorbable dentin graft material for the repair and augmentation of bone defects. Privately held, the company was founded and is funded by leading clinicians and industry leaders. Located in central Israel, Ivory Graft benefits from the country’s innovative medical startup ecosystem. Ivory Dentin Graft™ - The First and Only Dentin Graft The Ivory Dentin Graft™ was developed based upon years of scientific research and peer-reviewed publications on the advantages of autologous dentin grafts. Dentin’s composition is very similar to bone, due to its high mineral phase and its tubular architecture. Dentin is considered an excellent bone graft substitute grafting material. Ivory Dentin Graft is an active organic matrix. It retains the natural form of the sourced porcine dentin as well as the protein matrix consisting largely of collagen, and has been adapted for use in dental procedures. For the best results and ideal hard tissue generation, physicomechanical properties of the graft should match that of the host bone, in addition to biological connectivity and bio-active organic matrix. Ivory Dentin Graft promotes new bone formation as well as promoting good integration between the host-bone and graft material. These two features are important for tissue regeneration and integration during early bone remodeling processes that follow tooth extraction and grafting, and facilitate osteogenic activity to promote successful subsequent implant placement. CE Marked (MDR 2017/745), Ivory Dentin Graft™ is a graft substitute, naturally sourced from porcine dentin, obtained by standardized and controlled manufacturing procedures. This unique dentin graft is safe and effective, has no additives, and carries no BSE risk. In the USA, Ivory Dentin Graft™ is not yet available for commercial use .

Using Advanced AI and Protein intelligence to introduce indication-specific functional proteins with a perfect fit for humans.